Jain, A.
Shafer, L.
Rothenmund, H.
Kim, C. A.
Samadder, J.
Gupta, S.
Singh, H. http://orcid.org/0000-0002-9354-2356
Article History
Received: 23 March 2019
Accepted: 31 May 2019
First Online: 11 June 2019
Compliance with Ethical Standards
:
: Dr. Singh has served on the advisory boards of PendoPharm, Ferring, Takeda, and Merck, received an unrestricted educational grant from Ferring and research funding from Merck Canada. Dr. Samadder is a consultant for Cancer Prevention Pharmaceuticals, Jansen Research and Development, and Mallinckrodt Pharmaceuticals. Dr. Kim has received research funding from Celgene. All other authors declare no conflict of interest.